Oxigene to raise $10 million via at-market issuance sales agreement

Agent MLV will help sell common shares to public through offering

By Devika Patel

Knoxville, Tenn., June 14 - Oxigene Inc. will raise $10 million through an at-the-market issuance sales agreement, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission. The stock sale will be conducted via agent MLV & Co. LLC.

Proceeds will be used for operations and general corporate purposes.

Oxigene is a pharmaceutical company located in Waltham, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.